Skip to main content
OpenTrials

Clinical trial condition

Pruritus

Explore clinical trials studying Pruritus. Study availability and eligibility vary by location and protocol.

331 public trials 35 recruiting studies
Refine in advanced search Browse all conditions

Pruritus trial results

Active, Not Recruiting

Safety, Tolerability and PK of ATTO-3712 in Healthy Volunteers and Patients With Atopic Dermatitis

NCT07205081

Conditions
Atopic Dermatitis (AD), Atopic Eczema, Atopic Eczema/Dermatitis (Non-Specific), +16 more
Locations
  • Attovia Clinical Site 203 Encinitas, California, United States
  • Attovia Clinical Site 202 Saint Joseph, Missouri, United States
  • Attovia Clinical Site 102 Peterborough, Ontario, Canada
  • Altasciences Montreal, Quebec, Canada
View Trial Details
Active, Not Recruiting

Phase 2b Study of EVO756 in Adults With Atopic Dermatitis

NCT07150845

Conditions
Atoptic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +14 more
Locations
  • Saguaro Dermatology Phoenix, Arizona, United States
  • Center for Dermatology Clinical Research Fremont, California, United States
  • Metropolis Dermatology - Downtown Los Angeles Los Angeles, California, United States
  • Skin and Beauty Center Pasadena, California, United States
View all 29 locations
View Trial Details
Active, Not Recruiting

Evaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver Disease (EXPAND)

NCT06553768

Conditions
Bile Duct Diseases, Biliary Atresia, Biliary Tract Diseases, +13 more
Locations
  • Children's Hospital Los Angeles (CHLA) Los Angeles, California, United States
  • Stanford Children's Health in Palo Alto Palo Alto, California, United States
  • Lurie Children's Hospital Chicago, Illinois, United States
  • NYU Langone Health New York, United States
View all 24 locations
View Trial Details
Active, Not Recruiting

Ivermectin Therapy for Scabies Infection in Children Younger Than 5 Years of Age (ITCHY Study)

NCT05500326

Conditions
Disease Attributes, Ectoparasitic Infestations, Infections, +14 more
Locations
  • Banchieng Health Centre Kasy District, Vientiane Province, Laos
  • Hinngoon Health Centre Kasy District, Vientiane Province, Laos
  • Kasy District Hospital Kasy District, Vientiane Province, Laos
  • Poonglack Health Centre Kasy District, Vientiane, Laos
View Trial Details
Active, Not Recruiting

Safety, Tolerability and PK of ATTO-1310 in Healthy Volunteers and Patients With Atopic Dermatitis and Patients With Chronic Pruritus

NCT06787586

Conditions
Atopic Dermatitis (AD), Atopic Eczema, Chronic Pruritus, +17 more
Locations
  • Attovia Clinical Site 103 Encinitas, California, United States
  • Attovia Clinical Site 116 Rocklin, California, United States
  • Attovia Clinical Site 107 Sacramento, California, United States
  • Attovia Clinical Site 109 Coral Gables, Florida, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

A Phase 2, Open-Label, Extension Study to Evaluate Long Term Safety and Clinical Activity of Briquilimab in Participants From Jasper-Sponsored Chronic Urticaria Trials

NCT06736262

Conditions
Chronic Disease, Chronic Urticaria, Disease Attributes, +13 more
Locations
  • Investigative Site 118 Birmingham, Alabama, United States
  • Investigative Site 108 Little Rock, Arkansas, United States
  • Investigative Site 105 San Diego, California, United States
  • Investigative Site 116 Tampa, Florida, United States
View all 19 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC)

NCT04663308

Conditions
Bile Duct Diseases, Biliary Tract Diseases, Cholangitis, +10 more
Locations
  • Southern California Research Center Coronado, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • University of California, Davis Sacramento, California, United States
  • California Pacific Medical Center Research Institute San Francisco, California, United States
View all 103 locations
View Trial Details
Active, Not Recruiting

Dose Escalation Trial Of Safety, Pharmacokinetic/Pharmacodynamic And Preliminary Clinical Activity of Briquilimab In Adult Patients With Chronic Spontaneous Urticaria (CSU)

NCT06162728

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +13 more
Locations
  • Site 118 Birmingham, Alabama, United States
  • Site 108 Little Rock, Arkansas, United States
  • Site 105 San Diego, California, United States
  • Site 113 Miami, Florida, United States
View all 23 locations
View Trial Details

Related conditions